Mark David Minden
Impact in
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Hematology 360
- Acute Myeloid Leukemia Research 311
- Hematopoietic Stem Cell Transplantation 27
- Chronic Myeloid Leukemia Treatments 24
- Oncology 55
- Cancer survivorship and care 14
- Co-authors
- John Edgar Dick (49 shared papers)Tsvee Lapidot (3 shared papers)Hermann Josef Vormoor (2 shared papers)Christian Sirard (2 shared papers)Barbara Murdoch (2 shared papers)T Hoang (3 shared papers)Michael A. Caligiuri (2 shared papers)Julio Roberto Cáceres‐Cortés (1 shared paper)
- Journals
- Blood (113 papers)Leukemia (28 papers)Leukemia Research (24 papers)British Journal of Haematology (17 papers)Proceedings of the National Academy of Sciences (12 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Mark David Minden
563 papers receiving 36.1k citations
Mark David Minden's Hit Papers
Peers
Comparison fields: 5 of 160
- Hematology 13.8k
- Cancer Research 3.4k
- Oncology 5.5k
- Genetics 1.5k
- Molecular Biology 8.4k
Countries citing papers authored by Mark David Minden
This map shows the geographic impact of Mark David Minden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark David Minden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark David Minden more than expected).
Fields of papers citing papers by Mark David Minden
This network shows the impact of papers produced by Mark David Minden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark David Minden. The network helps show where Mark David Minden may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark David Minden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 589 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Hit paper breakdown → | 1994 | 3888 |
| 2 | MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia Hit paper breakdown → | 2001 | 1465 |
| 3 | Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia Hit paper breakdown → | 2014 | 1194 |
| 4 | Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia Hit paper breakdown → | 2012 | 986 |
| 5 | International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts Hit paper breakdown → | 2015 | 985 |
| 6 | Stem cell gene expression programs influence clinical outcome in human leukemia Hit paper breakdown → | 2011 | 879 |
| 7 | Sensitive tumour detection and classification using plasma cell-free DNA methylomes Hit paper breakdown → | 2018 | 727 |
| 8 | A 17-gene stemness score for rapid determination of risk in acute leukaemia Hit paper breakdown → | 2016 | 691 |
| 9 | Prediction of acute myeloid leukaemia risk in healthy individuals Hit paper breakdown → | 2018 | 669 |
| 10 | Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations Hit paper breakdown → | 2010 | 620 |
| 11 | Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia Hit paper breakdown → | 2011 | 570 |
| 12 | The genomic landscape of hypodiploid acute lymphoblastic leukemia Hit paper breakdown → | 2013 | 566 |
| 13 | Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia Hit paper breakdown → | 2012 | 556 |
| 14 | A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects Hit paper breakdown → | 2018 | 513 |
| 15 | PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Hit paper breakdown → | 2019 | 463 |
| 16 | Tracing the origins of relapse in acute myeloid leukaemia to stem cells Hit paper breakdown → | 2017 | 458 |
| 17 | 2007 | 404 | |
| 18 | Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells Hit paper breakdown → | 2011 | 394 |
| 19 | High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults Hit paper breakdown → | 2017 | 354 |
| 20 | 1991 | 349 |
About Mark David Minden
Mark David Minden is a scholar working on Hematology, Oncology, Cancer Research, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 589 papers that have together received 37.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (311 papers), Acute Lymphoblastic Leukemia research (59 papers), Hematopoietic Stem Cell Transplantation (27 papers), Chronic Myeloid Leukemia Treatments (24 papers), Cell death mechanisms and regulation (19 papers), T-cell and B-cell Immunology (18 papers), Retinoids in leukemia and cellular processes (14 papers) and Cancer survivorship and care (14 papers). The work is most often cited by research in Hematology (13.8k citations), Cancer Research (3.4k citations), Oncology (5.5k citations), Genetics (1.5k citations) and Molecular Biology (8.4k citations). Mark David Minden has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include John Edgar Dick, Tsvee Lapidot, Hermann Josef Vormoor, Christian Sirard, Barbara Murdoch, T Hoang, Michael A. Caligiuri, Julio Roberto Cáceres‐Cortés, Aaron David Schimmer and Tak W. Mak. Their work appears in journals such as Blood, Leukemia, Leukemia Research, British Journal of Haematology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.